| |
|
|
| |
|
|
|
| Protein production and cGMP manufacturing |
|
Protein Production Services (PPS) is your partner for cGMP contract manufacturing services of monoclonal antibodies and other recombinant proteins for preclinical and Phase I/II clinical trials.
Our streamlined cGMP compliant technological platform offers a comprehensive package to our clients all the way from cloning to scale up and phase I and II bulk API.
|
|
|
|
|
| | |
| | | February 22, 2010 | | | | PPS is proud to announce that it was selected to participate in the EU 7th Framework Programme (FP7) for Research & Technological Development. The company will be part of a Stem Cell Consortium entitled "Cardio Repair European Multidisciplinary Initiative", which is due to start on March 1, 2010. | | more | | | | December 14, 2009 | | | | Protein Production Services Ltd. (PPS) announced today that the company had been awarded a second year grant from Israel's prestigious Office of the Chief Scientist (OCS) program of support for industrial R&D. The grant was designated by the OCS to partially fund the continuation of Factor VIIa process development and production program, as a part of the company's platform of "Biosimilars Plus". | | more | | | | February 10, 2010 | | | | PPS was invited to participate in the Thistle Bioscience Forum that took place on February 4th, 2010 in Edinburgh, Scotland. The company was part of an Israeli delegation sponsored by the UK Trade & Investment of the British Embassy in Israel. | | more | | | | September 1, 2009 | | | | PPS has entered into an agreement with BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell technologies and therapeutics, for cGMP production of BrainStorm's stem cell therapeutic product. The clinical-grade product will be used in a pre-clinical safety trial for the company’s innovative therapy for ALS.
| | more | | | | March 10. 2009 | | | | Seraffix started Phase I clinical trials that will include 15 patients. A clinical batch of the protein component for the trial was prepared and released by PPS. | | more | | | | February 10, 2009 | | | | PPS Participated in a business delegation to Thistle Bioscience Showcase Event in Edinburgh, Scotland on February 3-6 2009. The mission was organized by the UK Trade & Investment as part of its ongoing programme of developing links between the UK and Israel in the life sciences sector. | | more | | | | January 19, 2009 | | | | Dr. Eli Opper, Chief Scientist of the Ministry of Industry, Trade and Labor, visited PPS and was introduced to the company's facilities and services. | | more | | |
|
